The Development of Medications for the Treatment of Opiate and Cocaine Addictions:

Issues for the Government and Private Sector

Status: Available Now

Size: 272 pages, 6 x 9

Publication Year:1995

Print	List Price


PAPERBACK ISBN-10: 0-309-05244-0 ISBN-13: 978-0-309-05244-3	$37.00	Add to Cart

PDF			About PDF

Authors:
Carolyn E. Fulco, Catharyn T. Liverman, and Laurence E. Earley, Editors; Committee to Study Medication Development and Research at the National Institute on Drug Abuse, Institute of Medicine
Authoring Organizations

Description:
Pharmacotherapy, as a means of treating drug addiction in combination with other treatment modalities, has received too little attention from the research community, the pharmaceutical industry, public health officials, and the federal government. Medications to combat drug addiction could have ...
Read More

Paste into your Web page:

<!-- Start NAP Book Display -->
<object classid="clsid:d27cdb6e-ae6d-11cf-96b8-444553540000" codebase="http://download.macromedia.com/pub/shockwave/cabs/flash/swflash.cab#version=8,0,0,0" width="175" height="250" id="napbookwrapper" align="middle">
<param name="allowScriptAccess" value="always" />
<param name="movie" value="http://www.nap.edu/napbookwrapper.swf" />
<param name="quality" value="high" />
<param name="wmode" value="transparent" />
<param name="flashvars" value="wid=107211863820130522202842&record_id=4906" />
<embed src="http://www.nap.edu/napbookwrapper.swf" quality="high" flashvars="wid=107211863820130522202842&record_id=4906" wmode="transparent" bgcolor="#ffffff" width="175" height="250" name="napbookwrapper" align="middle" allowScriptAccess="always" allowFullScreen="false" type="application/x-shockwave-flash" pluginspage="http://www.macromedia.com/go/getflashplayer"></embed>
</object>

Preview

Free Resources

Full Text
Jump to this book's table of contents to begin reading online for free.

Related Items:
Related Titles

PDF Summary
Download the summary in PDF.

Reprint Permission
Request permission to license or reprint the book's content through Copyright Clearance Center's Rightslink.

Request Permission to Distribute a PDF

Request Translation Rights

Questions About Rights and Permissions?

Table of Contents
Select a link below to start reading online free!
Front Matter	i-xx
Executive Summary	1-25	(skim)
1 Introduction	26-42	(skim)
2 Overview of the State of Scientific Knowledge Concerning Drug Addiction	43-73	(skim)
3 Assessment of the Medications Development Division	74-94	(skim)
4 Treatment Setting and Effectiveness	95-119	(skim)
5 Treatment Financing and Trends in Health Insurance	120-133	(skim)
6 Training and Education	134-153	(skim)
7 Federal Laws and Regulations	154-172	(skim)
8 State Laws and Regulations	173-186	(skim)
9 Market Obstacles and Creating Incentives	187-200	(skim)
Appendix A: Acknowledgments	201-206	(skim)
Appendix B: Organization and Mission Statements of NIDA's Medications Development Division and Its Branches	207-210	(skim)
Appendix C: Diagnostic Criteria for Psychoactive Substance Dependence	211-214	(skim)
Appendix D: Survey of Pharmaceutical Companies	215-226	(skim)
Appendix E: Model Federal Programs in Pharmaceutical R&D	227-237	(skim)
Appendix F: Workshop Agenda and Participants	238-241	(skim)
Appendix G: Health Care Reform Legislation	242-247	(skim)
Appendix H: Acronyms	248-250	(skim)

Description

Pharmacotherapy, as a means of treating drug addiction in combination with other treatment modalities, has received too little attention from the research community, the pharmaceutical industry, public health officials, and the federal government. Medications to combat drug addiction could have an enormous impact on the medical consequences and socioeconomic problems associated with drug abuse, both for drug-dependent individuals and for American society as a whole. This book examines the current environment for and obstacles to the development of anti-addiction medications, specifically those for treating opiate and cocaine addictions, and proposes incentives for the pharmaceutical industry that would help overcome those obstacles and accelerate the development of anti-addiction medications.

Authoring Organizations

Institute of Medicine (IOM)

More Titles from IOM

Search This Book

»Find more like this book

SIGN UP FOR...

New Title Emails
Read about the newest releases and receive special offers.